Cleared Traditional

K091762 - DURA-STICK SELF-ADHESIVE ELECTRODES WITH ALOE

K091762 is an FDA 510(k) clearance for DURA-STICK SELF-ADHESIVE ELECTRODES WIT..., manufactured by Covidien. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 189-day FDA review.

K091762 · Covidien · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2009
Decision
189d
Days
Class 2
Risk

K091762 is an FDA 510(k) clearance for the DURA-STICK SELF-ADHESIVE ELECTRODES WITH ALOE. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Covidien (Mansfield, US). The FDA issued a Cleared decision on December 22, 2009 after a review of 189 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Covidien devices

FDA 510(k) Submission Details - K091762

510(k) Number K091762 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 16, 2009
Decision Date December 22, 2009
Days to Decision 189 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 148d · This submission: 189d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 290
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K091762.
WAVEGUARD (TM) EEG CAP
K110223 · Eemagine Medical Imaging Solutions GmbH · Jun 2011
AVIVAFIX CONDUCTIVE GARMENT-KNEE/SHOULDER/UPPER BACK, TYPE 40
K102614 · Bio-Medical Research, Ltd. · Jun 2011
SUPERIOR STARBURST REUSABLE SELF-ADHERING TENS/NMES/FES STIMULATING ELECTRODE
K100418 · Covidien · Sep 2010
MODIFICATION TO:KNEEHAB XP CONDUCTIVE GARMENT, MODEL 411
K092793 · Bio-Medical Research, Ltd. · Dec 2009
BIS QUATRO SENSOR
K093183 · Aspect Medical Systems, Inc. · Oct 2009
LIFECARE ELECTRODES
K083302 · Everyway Medical Instruments Co.,Ltd · Aug 2009